chr20_+_19915716
|
3.597
|
|
RIN2
|
Ras and Rab interactor 2
|
chr4_+_75310852
|
3.125
|
NM_001657
|
AREG
|
amphiregulin
|
chr4_+_75480628
|
2.993
|
NM_001657
|
AREG
|
amphiregulin
|
chr11_+_12695851
|
2.911
|
NM_021961
|
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor)
|
chr2_-_216300770
|
2.601
|
NM_002026
NM_054034
NM_212474
NM_212476
NM_212478
NM_212482
|
FN1
|
fibronectin 1
|
chr2_-_224903324
|
2.052
|
NM_001136530
|
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
|
chr12_+_13044352
|
2.037
|
|
GPRC5A
|
G protein-coupled receptor, family C, group 5, member A
|
chr11_+_117070039
|
1.774
|
NM_001001522
NM_003186
|
TAGLN
|
transgelin
|
chr1_+_156030965
|
1.722
|
NM_020387
|
RAB25
|
RAB25, member RAS oncogene family
|
chr21_-_27253197
|
1.674
|
|
APP
|
amyloid beta (A4) precursor protein
|
chrX_-_13835187
|
1.663
|
|
GPM6B
|
glycoprotein M6B
|
chr3_+_62304667
|
1.661
|
|
C3orf14
|
chromosome 3 open reading frame 14
|
chrX_-_13835012
|
1.631
|
|
GPM6B
|
glycoprotein M6B
|
chr15_-_63674074
|
1.618
|
NM_001218
NM_206925
|
CA12
|
carbonic anhydrase XII
|
chr20_-_14318200
|
1.618
|
NM_013281
NM_198391
|
FLRT3
|
fibronectin leucine rich transmembrane protein 3
|
chr3_+_158991035
|
1.529
|
NM_001197107
NM_001197108
NM_014575
|
SCHIP1
|
schwannomin interacting protein 1
|
chr12_+_13044493
|
1.482
|
|
GPRC5A
|
G protein-coupled receptor, family C, group 5, member A
|
chr8_-_42065193
|
1.474
|
NM_000930
NM_033011
|
PLAT
|
plasminogen activator, tissue
|
chr3_+_187871473
|
1.453
|
NM_001167672
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
chr16_-_79634610
|
1.443
|
NM_001031804
NM_005360
|
MAF
|
v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian)
|
chr8_-_42065037
|
1.440
|
|
PLAT
|
plasminogen activator, tissue
|
chr15_-_63673918
|
1.387
|
|
CA12
|
carbonic anhydrase XII
|
chr20_+_4666796
|
1.379
|
NM_000311
NM_001080121
NM_001080122
NM_183079
NM_001080123
|
PRNP
|
prion protein
|
chr12_-_91505215
|
1.368
|
|
LUM
|
lumican
|
chr16_-_4588738
|
1.341
|
NM_001199055
NM_001199056
NM_013399
|
C16orf5
|
chromosome 16 open reading frame 5
|
chr7_-_129592794
|
1.337
|
NM_003344
NM_182697
|
UBE2H
|
ubiquitin-conjugating enzyme E2H
|
chr21_-_43187197
|
1.314
|
NM_020639
|
RIPK4
|
receptor-interacting serine-threonine kinase 4
|
chrX_-_10645726
|
1.285
|
NM_001098624
|
MID1
|
midline 1 (Opitz/BBB syndrome)
|
chr21_-_43187265
|
1.279
|
|
RIPK4
|
receptor-interacting serine-threonine kinase 4
|
chr6_-_47277646
|
1.277
|
NM_014452
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
chr2_-_216300444
|
1.275
|
|
FN1
|
fibronectin 1
|
chr7_-_41742666
|
1.263
|
NM_002192
|
INHBA
|
inhibin, beta A
|
chr4_+_85504056
|
1.241
|
NM_001263
|
CDS1
|
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1
|
chr12_-_91505541
|
1.234
|
NM_002345
|
LUM
|
lumican
|
chr13_-_45010937
|
1.232
|
|
TSC22D1
|
TSC22 domain family, member 1
|
chr2_-_238322770
|
1.218
|
|
COL6A3
|
collagen, type VI, alpha 3
|
chr6_-_47277511
|
1.204
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
chr2_-_238322840
|
1.203
|
NM_004369
NM_057164
NM_057165
NM_057166
NM_057167
|
COL6A3
|
collagen, type VI, alpha 3
|
chr1_+_99730067
|
1.199
|
|
LPPR4
|
lipid phosphate phosphatase-related protein type 4
|
chr4_-_156297944
|
1.189
|
|
MAP9
|
microtubule-associated protein 9
|
chr12_+_13043955
|
1.181
|
NM_003979
|
GPRC5A
|
G protein-coupled receptor, family C, group 5, member A
|
chrX_-_128657453
|
1.126
|
NM_003069
NM_139035
|
SMARCA1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1
|
chr1_-_16482426
|
1.126
|
NM_004431
|
EPHA2
|
EPH receptor A2
|
chr13_+_48807492
|
1.105
|
|
ITM2B
|
integral membrane protein 2B
|
chrX_-_128657440
|
1.084
|
|
SMARCA1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1
|
chr4_-_156297973
|
1.067
|
|
MAP9
|
microtubule-associated protein 9
|
chr7_-_129592711
|
1.063
|
NM_001202498
|
UBE2H
|
ubiquitin-conjugating enzyme E2H
|
chr2_-_238322815
|
1.056
|
|
COL6A3
|
collagen, type VI, alpha 3
|
chr11_-_8892909
|
1.053
|
|
ST5
|
suppression of tumorigenicity 5
|
chrX_-_13835313
|
1.049
|
NM_001001995
NM_001001996
NM_005278
|
GPM6B
|
glycoprotein M6B
|
chrX_-_13956644
|
1.047
|
NM_001001994
|
GPM6B
|
glycoprotein M6B
|
chr3_-_99594915
|
1.022
|
NM_014890
|
FILIP1L
|
filamin A interacting protein 1-like
|
chr9_+_97488943
|
1.017
|
NM_001193331
NM_032823
|
C9orf3
|
chromosome 9 open reading frame 3
|
chr6_-_47277354
|
1.012
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
chr9_+_97488993
|
1.004
|
|
C9orf3
|
chromosome 9 open reading frame 3
|
chr8_+_70405080
|
0.993
|
|
SULF1
|
sulfatase 1
|
chr10_-_99446899
|
0.987
|
NM_021732
|
AVPI1
|
arginine vasopressin-induced 1
|
chr7_+_130131172
|
0.972
|
NM_177525
|
MEST
|
mesoderm specific transcript homolog (mouse)
|
chr22_+_38597938
|
0.966
|
NM_001161572
NM_001161574
NM_012323
|
MAFF
|
v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian)
|
chr8_+_98788014
|
0.958
|
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta
|
chr10_+_123923104
|
0.922
|
NM_006997
NM_206860
|
TACC2
|
transforming, acidic coiled-coil containing protein 2
|
chr5_+_34687663
|
0.921
|
NM_001145523
|
RAI14
|
retinoic acid induced 14
|
chr4_-_156298094
|
0.913
|
NM_001039580
|
MAP9
|
microtubule-associated protein 9
|
chr1_-_1293907
|
0.909
|
NM_032348
|
MXRA8
|
matrix-remodelling associated 8
|
chr21_+_47545189
|
0.904
|
|
COL6A2
|
collagen, type VI, alpha 2
|
chr21_-_27512668
|
0.890
|
NM_001136016
|
APP
|
amyloid beta (A4) precursor protein
|
chr6_-_47277246
|
0.885
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
chr4_+_74269971
|
0.858
|
NM_000477
|
ALB
|
albumin
|
chr8_+_26240522
|
0.825
|
NM_004331
|
BNIP3L
|
BCL2/adenovirus E1B 19kDa interacting protein 3-like
|
chr10_-_5045967
|
0.823
|
NM_001135241
|
AKR1C2
|
aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III)
|
chr5_-_175843531
|
0.820
|
NM_001834
NM_007097
|
CLTB
|
clathrin, light chain B
|
chr10_+_5005453
|
0.813
|
NM_001353
|
AKR1C1
|
aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)
|
chr14_+_96671015
|
0.811
|
NM_000623
|
BDKRB2
|
bradykinin receptor B2
|
chr6_+_139456240
|
0.789
|
NM_016217
|
HECA
|
headcase homolog (Drosophila)
|
chr12_+_56915587
|
0.776
|
NM_002898
|
RBMS2
|
RNA binding motif, single stranded interacting protein 2
|
chrX_+_107683015
|
0.770
|
NM_000495
NM_033380
|
COL4A5
|
collagen, type IV, alpha 5
|
chr8_+_94929991
|
0.765
|
NM_001161778
|
PDP1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1
|
chrX_-_13956530
|
0.763
|
|
GPM6B
|
glycoprotein M6B
|
chrX_+_43514157
|
0.755
|
|
MAOA
|
monoamine oxidase A
|
chr8_-_95274540
|
0.753
|
NM_005261
NM_181702
|
GEM
|
GTP binding protein overexpressed in skeletal muscle
|
chr10_+_5005601
|
0.752
|
|
AKR1C1
AKR1C3
|
aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)
aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II)
|
chr20_-_56284945
|
0.751
|
NM_020182
|
PMEPA1
|
prostate transmembrane protein, androgen induced 1
|
chr16_-_10674443
|
0.746
|
NM_001424
|
EMP2
|
epithelial membrane protein 2
|
chr10_+_5005685
|
0.738
|
|
AKR1C1
|
aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)
|
chr5_-_172198160
|
0.734
|
NM_004417
|
DUSP1
|
dual specificity phosphatase 1
|
chr8_-_95274520
|
0.729
|
|
GEM
|
GTP binding protein overexpressed in skeletal muscle
|
chr11_+_35639734
|
0.726
|
NM_014344
|
FJX1
|
four jointed box 1 (Drosophila)
|
chr5_-_175843360
|
0.722
|
|
CLTB
|
clathrin, light chain B
|
chr22_+_38598065
|
0.706
|
|
MAFF
|
v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian)
|
chrX_-_128657381
|
0.705
|
|
SMARCA1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1
|
chr1_-_59249687
|
0.703
|
NM_002228
|
JUN
|
jun proto-oncogene
|
chr9_-_14086901
|
0.701
|
|
NFIB
|
nuclear factor I/B
|
chr12_-_102455793
|
0.699
|
NM_016053
|
CCDC53
|
coiled-coil domain containing 53
|
chr1_-_201476241
|
0.697
|
|
CSRP1
|
cysteine and glycine-rich protein 1
|
chr5_+_36606456
|
0.691
|
NM_001166696
NM_004172
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3
|
chr5_+_73109342
|
0.690
|
NM_001244364
|
RGNEF
|
190 kDa guanine nucleotide exchange factor
|
chr1_-_201476218
|
0.669
|
|
CSRP1
|
cysteine and glycine-rich protein 1
|
chr8_+_94929082
|
0.668
|
NM_018444
NM_001161780
NM_001161779
NM_001161781
|
PDP1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1
|
chr3_+_8543508
|
0.665
|
NM_014583
|
LMCD1
|
LIM and cysteine-rich domains 1
|
chr2_-_220408264
|
0.662
|
NM_024536
|
CHPF
|
chondroitin polymerizing factor
|
chr21_-_36421630
|
0.650
|
|
RUNX1
|
runt-related transcription factor 1
|
chr2_+_201473942
|
0.647
|
|
AOX1
|
aldehyde oxidase 1
|
chr20_+_43803539
|
0.631
|
NM_002638
|
PI3
|
peptidase inhibitor 3, skin-derived
|
chr9_-_129884885
|
0.629
|
|
ANGPTL2
|
angiopoietin-like 2
|
chr9_-_129884998
|
0.621
|
NM_012098
|
ANGPTL2
|
angiopoietin-like 2
|
chr8_-_145025043
|
0.621
|
NM_201380
|
PLEC
|
plectin
|
chr3_-_48130633
|
0.606
|
NM_001134364
NM_002375
NM_030885
|
MAP4
|
microtubule-associated protein 4
|
chr12_-_102455763
|
0.606
|
|
CCDC53
|
coiled-coil domain containing 53
|
chr3_-_187463474
|
0.602
|
NM_001706
|
BCL6
|
B-cell CLL/lymphoma 6
|
chrX_-_10535476
|
0.595
|
NM_001193278
NM_001193279
NM_001193280
NM_001193281
|
MID1
|
midline 1 (Opitz/BBB syndrome)
|
chr10_+_124151818
|
0.595
|
NM_021622
|
PLEKHA1
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1
|
chr17_+_66508564
|
0.589
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)
|
chr5_+_36606667
|
0.587
|
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3
|
chr8_+_132916339
|
0.572
|
NM_015137
|
EFR3A
|
EFR3 homolog A (S. cerevisiae)
|
chr6_+_148663728
|
0.571
|
NM_015278
|
SASH1
|
SAM and SH3 domain containing 1
|
chrX_-_13835213
|
0.566
|
|
GPM6B
|
glycoprotein M6B
|
chr5_+_138211084
|
0.564
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
chr20_+_9288446
|
0.552
|
NM_000933
|
PLCB4
|
phospholipase C, beta 4
|
chr1_-_209979388
|
0.552
|
NM_001206696
NM_006147
|
IRF6
|
interferon regulatory factor 6
|
chr1_+_160175146
|
0.549
|
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
chr14_-_69354900
|
0.545
|
|
ACTN1
|
actinin, alpha 1
|
chr5_+_150399980
|
0.544
|
NM_002084
|
GPX3
|
glutathione peroxidase 3 (plasma)
|
chr6_+_39760148
|
0.543
|
NM_001201427
|
DAAM2
|
dishevelled associated activator of morphogenesis 2
|
chr1_+_99729847
|
0.541
|
NM_001166252
NM_014839
|
LPPR4
|
lipid phosphate phosphatase-related protein type 4
|
chr4_+_41700736
|
0.527
|
|
LIMCH1
|
LIM and calponin homology domains 1
|
chr1_-_201476248
|
0.524
|
NM_001193570
NM_004078
|
CSRP1
|
cysteine and glycine-rich protein 1
|
chr10_-_3827418
|
0.523
|
NM_001160124
NM_001160125
NM_001300
|
KLF6
|
Kruppel-like factor 6
|
chr2_-_73316782
|
0.520
|
|
RAB11FIP5
|
RAB11 family interacting protein 5 (class I)
|
chr17_-_13505217
|
0.518
|
NM_006042
|
HS3ST3A1
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1
|
chr17_+_41476351
|
0.517
|
NM_001661
|
ARL4D
|
ADP-ribosylation factor-like 4D
|
chr11_+_61447816
|
0.512
|
NM_006133
|
DAGLA
|
diacylglycerol lipase, alpha
|
chr5_+_32711437
|
0.506
|
NM_000908
NM_001204375
|
NPR3
|
natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C)
|
chr5_+_140767402
|
0.505
|
NM_003736
NM_032098
|
PCDHGB4
|
protocadherin gamma subfamily B, 4
|
chr14_+_104095491
|
0.505
|
NM_001130107
NM_005552
NM_182923
|
KLC1
|
kinesin light chain 1
|
chr21_+_39628869
|
0.504
|
NM_170736
|
KCNJ15
|
potassium inwardly-rectifying channel, subfamily J, member 15
|
chr21_-_36421586
|
0.504
|
NM_001754
|
RUNX1
|
runt-related transcription factor 1
|
chr9_+_97521930
|
0.503
|
NM_001193329
|
C9orf3
|
chromosome 9 open reading frame 3
|
chr11_-_66725790
|
0.501
|
NM_000920
NM_001040716
|
PC
|
pyruvate carboxylase
|
chr1_-_201475966
|
0.500
|
NM_001193571
|
CSRP1
|
cysteine and glycine-rich protein 1
|
chr8_-_49833823
|
0.494
|
NM_003068
|
SNAI2
|
snail homolog 2 (Drosophila)
|
chr17_-_77770776
|
0.492
|
NM_020649
|
CBX8
|
chromobox homolog 8
|
chr14_+_101292483
|
0.489
|
|
|
|
chr12_-_6862131
|
0.486
|
|
MLF2
|
myeloid leukemia factor 2
|
chr4_-_186456580
|
0.486
|
NM_001114107
NM_014476
|
PDLIM3
|
PDZ and LIM domain 3
|
chr5_+_71502700
|
0.484
|
|
MAP1B
|
microtubule-associated protein 1B
|
chr14_-_69259654
|
0.476
|
|
ZFP36L1
|
zinc finger protein 36, C3H type-like 1
|
chr3_-_48130283
|
0.474
|
|
MAP4
|
microtubule-associated protein 4
|
chr1_+_160175114
|
0.472
|
NM_003768
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
chr12_+_56552141
|
0.470
|
|
MYL6
|
myosin, light chain 6, alkali, smooth muscle and non-muscle
|
chr19_+_39279849
|
0.469
|
NM_001042507
|
LGALS7B
|
lectin, galactoside-binding, soluble, 7B
|
chr14_+_101292451
|
0.469
|
|
MEG3
|
maternally expressed 3 (non-protein coding)
|
chr20_-_56285576
|
0.468
|
NM_199169
NM_199170
|
PMEPA1
|
prostate transmembrane protein, androgen induced 1
|
chr19_-_52227220
|
0.468
|
NM_001523
|
HAS1
|
hyaluronan synthase 1
|
chr19_-_44174497
|
0.466
|
NM_001005376
NM_001005377
NM_002659
|
PLAUR
|
plasminogen activator, urokinase receptor
|
chr16_-_4588379
|
0.465
|
NM_001199054
|
C16orf5
|
chromosome 16 open reading frame 5
|
chr5_+_66124603
|
0.464
|
NM_015183
|
MAST4
|
microtubule associated serine/threonine kinase family member 4
|
chrX_+_110339374
|
0.463
|
NM_002578
|
PAK3
|
p21 protein (Cdc42/Rac)-activated kinase 3
|
chr2_-_31637553
|
0.458
|
|
XDH
|
xanthine dehydrogenase
|
chr11_-_33795892
|
0.458
|
NM_012175
NM_033406
|
FBXO3
|
F-box protein 3
|
chr1_+_183114214
|
0.455
|
|
LAMC1
|
laminin, gamma 1 (formerly LAMB2)
|
chr14_+_96722546
|
0.453
|
NM_000710
|
BDKRB1
|
bradykinin receptor B1
|
chr5_-_1882764
|
0.451
|
NM_016358
|
IRX4
|
iroquois homeobox 4
|
chr8_-_116681103
|
0.439
|
NM_014112
|
TRPS1
|
trichorhinophalangeal syndrome I
|
chr11_-_73472057
|
0.438
|
NM_001243718
NM_002869
NM_198896
|
RAB6A
|
RAB6A, member RAS oncogene family
|
chr20_-_34025955
|
0.438
|
NM_000557
|
GDF5
|
growth differentiation factor 5
|
chr3_-_99833348
|
0.429
|
NM_001042459
NM_182909
|
FILIP1L
|
filamin A interacting protein 1-like
|
chr5_-_95297424
|
0.428
|
|
ELL2
|
elongation factor, RNA polymerase II, 2
|
chr8_+_98787808
|
0.428
|
NM_018407
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta
|
chrX_+_114827818
|
0.425
|
NM_001136025
NM_001172335
|
PLS3
|
plastin 3
|
chr12_-_102455739
|
0.423
|
|
CCDC53
|
coiled-coil domain containing 53
|
chr3_-_55521330
|
0.423
|
NM_003392
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
chr2_+_148602569
|
0.422
|
NM_001616
|
ACVR2A
|
activin A receptor, type IIA
|
chr5_-_95297597
|
0.422
|
NM_012081
|
ELL2
|
elongation factor, RNA polymerase II, 2
|
chr6_-_46459010
|
0.418
|
NM_001251974
|
RCAN2
|
regulator of calcineurin 2
|
chr17_-_80231560
|
0.414
|
NM_001893
NM_139062
|
CSNK1D
|
casein kinase 1, delta
|
chr14_+_61447831
|
0.407
|
NM_001172702
NM_153811
|
SLC38A6
|
solute carrier family 38, member 6
|
chr17_+_33914320
|
0.406
|
|
AP2B1
|
adaptor-related protein complex 2, beta 1 subunit
|
chr4_+_668250
|
0.406
|
|
MYL5
|
myosin, light chain 5, regulatory
|
chr1_+_29562947
|
0.403
|
NM_001195001
NM_005704
NM_133177
NM_133178
|
PTPRU
|
protein tyrosine phosphatase, receptor type, U
|
chr3_+_8543539
|
0.402
|
|
LMCD1
|
LIM and cysteine-rich domains 1
|
chr3_-_185826748
|
0.402
|
NM_004454
|
ETV5
|
ets variant 5
|
chr7_+_143078608
|
0.400
|
|
ZYX
|
zyxin
|
chr6_+_148663953
|
0.396
|
|
SASH1
|
SAM and SH3 domain containing 1
|
chr5_-_121413967
|
0.396
|
|
LOX
|
lysyl oxidase
|
chr19_+_45349560
|
0.394
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
chr12_+_122150638
|
0.393
|
NM_001080825
|
TMEM120B
|
transmembrane protein 120B
|
chr10_-_3827205
|
0.388
|
|
KLF6
|
Kruppel-like factor 6
|
chr1_-_1284755
|
0.386
|
|
DVL1
|
dishevelled, dsh homolog 1 (Drosophila)
|
chr2_+_183582667
|
0.385
|
|
DNAJC10
|
DnaJ (Hsp40) homolog, subfamily C, member 10
|
chr8_+_70405027
|
0.381
|
NM_001128205
NM_001128206
|
SULF1
|
sulfatase 1
|
chr6_-_3157696
|
0.379
|
NM_001069
|
TUBB2A
|
tubulin, beta 2A class IIa
|
chr6_-_46293404
|
0.379
|
|
RCAN2
|
regulator of calcineurin 2
|
chr17_+_66508525
|
0.379
|
NM_002734
NM_212472
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)
|
chr1_+_110527399
|
0.379
|
|
AHCYL1
|
adenosylhomocysteinase-like 1
|
chr4_-_111558150
|
0.378
|
|
PITX2
|
paired-like homeodomain 2
|
chr1_-_221915458
|
0.376
|
NM_007207
NM_144729
|
DUSP10
|
dual specificity phosphatase 10
|
chr12_-_123380628
|
0.376
|
|
VPS37B
|
vacuolar protein sorting 37 homolog B (S. cerevisiae)
|
chr21_+_39628663
|
0.375
|
NM_002243
|
KCNJ15
|
potassium inwardly-rectifying channel, subfamily J, member 15
|
chr9_-_32552550
|
0.373
|
|
TOPORS
|
topoisomerase I binding, arginine/serine-rich, E3 ubiquitin protein ligase
|
chr8_-_21966812
|
0.360
|
NM_024815
|
NUDT18
|
nudix (nucleoside diphosphate linked moiety X)-type motif 18
|